Verastem Oncology to Present at the 2021 Jefferies Virtual Healthcare Conference
Verastem, a biopharmaceutical company focused on cancer treatment, announced its participation in the 2021 Jefferies Virtual Healthcare Conference on June 1, 2021, at 4:00 p.m. ET. A live webcast of the presentation will be available on the Company’s website, with an archived version accessible for 30 days post-event. Verastem specializes in developing new medicines targeting critical cancer signaling pathways, aiming to enhance patient quality of life.
- None.
- None.
Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will present at the 2021 Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:00 p.m. ET.
A live webcast of the presentation will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 30 days.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005310/en/
FAQ
When will Verastem present at the Jefferies Virtual Healthcare Conference?
How can I watch Verastem's presentation at the conference?
Will the Verastem presentation be available after the event?
What is Verastem's focus in cancer treatment?
What stock exchange is Verastem listed on?
